Navigation Links
Cardium and SourceOne Global Partners Enter Into Cross-Strategic Equity Investment with Plans to Jointly Develop Nutritional Supplements and Medical Foods
Date:12/21/2011

ceutical products, as well as pharmaceutical and medical food product candidates designed to support cardiovascular health. We believe Cardium's extensive clinical research and development experience, combined with their business acumen, will be instrumental in expanding our leadership role in the nutritional marketplace." 

Under the agreement, Cardium has made a $0.75 million equity investment in the form of unregistered, restricted Cardium shares to acquire rights to a 15% ownership interest in SourceOne Global Partners.  Cardium's ownership interest was acquired through the issuance into escrow of 1.5 million shares of Cardium common stock based on a $0.50 per share value representing a 70% premium above the closing price of Cardium stock on December 19, 2011.  The shares would be held in escrow and subject to release in four allotments at 6, 9, 12 and 18 months following the closing date.  Cardium also has certain rights to maintain its proportionate ownership interest in SourceOne, and to acquire SourceOne in the event SourceOne were to receive an offer from a third-party acquiror.

In parallel with the cross-equity investment and acquisition of an ownership interest in SourceOne, Cardium also received a license for a portfolio of nutraceutical, pharmaceutical and medical food product opportunities for a licensing fee of $0.75 million, which SourceOne applied to the purchase of 1.5 million restricted shares of Cardium common stock at $0.50 per share, which shares are to be held in escrow for six months and subject to release at future dates thereafter based on Cardium's advancement of certain jointly-developed products.  Under terms of the licensing arrangement, Cardium received a fully-paid-up license to commercialize formulations of various SourceOne ingredients to be marketed as nutraceuticals, pharmaceuticals and/or medical foods.  In addition, Cardium can designate up to ten products to be jointly developed by t
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cardium to Present at the Rodman & Renshaw Annual Healthcare Investment Conference
2. Cardium Provides Update on Exchange Listing and Related Business Matters
3. Cardium to Present at Southern California Investor Conference
4. Cardium Announces Receipt of $1.1 Million in Funds from Philips Acquisition of Innercool Therapies
5. Cardium Presents Second Quarter 2011 Financial Results and Reports on Near-Term Milestones
6. Cardium Provides Update on Excellagen 510(K) Registration and Commercialization Plans
7. Cardium Reports on Transdel Transaction
8. Cardium Announces Market Introduction of New Alena™ Clinical Strength Carb Blocker to Expand the MedPodium Healthy Lifestyle Product Line
9. Cardium Announces Plans to Acquire Transdel Pharmaceuticals Phase 3 Topical Analgesic and Cosmeceutical Business Assets
10. Cardium Announces Cedars-Sinai Heart Institute as the SPECT Imaging Core Lab for the Recently Announced Generx® Phase 3 Clinical Registration Study in the Russian Federation
11. Cardium Presents First Quarter 2011 Financial Results and Reports on Near-Term Milestones
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... June 30, 2015   Millar, Inc. , a ... announced the 2016 retirement of Craig Thummel , ... 12 years of service to the Company. The Company ... senior members of the Executive Management team as his ... Daugherty , currently Director of Sales and Marketing, as ...
(Date:6/30/2015)... NEW YORK , June 30, 2015 /PRNewswire/ ... a late stage pharmaceutical company focused on the ... today announced the closing of its previously announced ... stock. The underwriters also exercised their over-allotment option ... of common stock. The net proceeds ...
(Date:6/30/2015)... June 24, 2015 ... addition of the "Global Array Instruments Market ... The global array instruments market to grow at ... 2014-2019 The global array instruments market can ... microarrays, and others including tissue microarrays and cell ...
Breaking Medicine Technology:Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Dipexium Announces Closing of Public Offering of Common Stock 2Dipexium Announces Closing of Public Offering of Common Stock 3Global Array Instruments Market 2015-2019 - Advances in Personalized Medicines with Affymetrix, Agilent Technologies & Illumina Dominating 2
... Roche announced today the opening of a new ... Nutley, N.J. The Roche Center of Excellence produces dosage ... and Phase 1 and 2 clinical studies. The 17,000 ... compounds into medicines for clinical trials. ...
... Sept. 30, 2011 The CyberKnife Coalition ... the CyberKnife Robotic Radiosurgery System® have now been enrolled ... track prostate cancer patients treated with stereotactic ... Radiosurgery (RPCR), tracks clinical and functional outcomes of men ...
Cached Medicine Technology:Roche Opens New Center of Excellence Facility 2First Prostate Cancer Registry for Robotic Radiosurgery Patients Enrolls More than 500 Men 2
(Date:6/30/2015)... CA (PRWEB) , ... June 30, 2015 , ... ... the community. , Eleven physicians from Allied’s Fullerton division volunteered to help provide ... annual Super Surgery Saturday, March 21, at St. Jude Medical Center. , ...
(Date:6/30/2015)... ... June 30, 2015 , ... CCAR is pleased to announce its expansion of ... Willimantic and Bridgeport. This month, staff member Jim Higgins left his role as ... is excited to take on this role of organizing peer recovery support available through ...
(Date:6/30/2015)... ... June 30, 2015 , ... An opinion piece published May ... procedures had over breast implants when reconstructing breasts after a mastectomy. The author ... feel natural,” have increased sensation, and are less likely than implant reconstructions to ...
(Date:6/30/2015)... ... ... After more than five years of research and development that includes active ... formulated for the unique skin of all people of color — is now available. ... to help protect the skin of all people of color this July Fourth holiday ...
(Date:6/30/2015)... , ... June 30, 2015 ... ... the drug response profiling test to help oncologists provide personalized cancer treatment, ... “The CorrectChemo® assay provides the oncologist with valuable insight on how a ...
Breaking Medicine News(10 mins):Health News:Allied Anesthesia Physicians Volunteer to Help Orange County’s Uninsured During Annual Super Surgery Saturday 2Health News:Allied Anesthesia Physicians Volunteer to Help Orange County’s Uninsured During Annual Super Surgery Saturday 3Health News:The Connecticut Community for Addiction Recovery takes Recovery Coaching to a new level 2Health News:Recent Article Advocating for Breast Reconstruction with Fat Transfers Successfully Outlines the Advantages of Transfer Procedures, Notes Beverly Hills Physicians 2Health News:Recent Article Advocating for Breast Reconstruction with Fat Transfers Successfully Outlines the Advantages of Transfer Procedures, Notes Beverly Hills Physicians 3Health News:GlobalSun – The First Sunscreen Developed for All People of Color – Hits The Market 2Health News:Correct Chemo Joins NextGxDx Online Genetic Testing Marketplace 2Health News:Correct Chemo Joins NextGxDx Online Genetic Testing Marketplace 3
... ... 40th anniversary of Earth Day, Zagpromos.com and the Earth Day Network have launched an ... environmental education and green schools. , ... Orangeburg, NY (PRWEB) March 30, 2010 -- Zagpromos.com, a one-stop online ...
... time to discard the word euthanasia because it mixes ... dying, states an editorial in CMAJ ( ... http://www.cmaj.ca/embargo/cmaj100338.pdf . "The end of life debate seems ... Dr. Ken Flegel, Senior Associate Editor and Dr. Paul ...
... they are less likely to breast-feed than other women ... attitudes about breast-feeding may explain why black American women ... infants, a new study shows. , About 60 percent ... compared with 77 percent of white infants, according to ...
... genes in breast tissue of women who have previously ... pregnancy-associated breast cancer, according to new research at the ... a relatively young age reduces the risk of breast ... found that women are at an increased risk for ...
... CITY A team of scientists including University of Utah ... the hepatitis C virus (HCV) to the genetic material of ... affect the ability of the virus to replicate. This discovery, ... Proceedings of the National Academy of Sciences , provides a ...
... were 50% more likely to die in month following ... 2 diabetics newly diagnosed with cancer have an increased ... surgery, compared to people who are battling cancer alone. ... colorectal or esophageal cancers, Johns Hopkins researchers found. , ...
Cached Medicine News:Health News:Zagpromos.com Launches Online Store for Earth Day Network 2Health News:Zagpromos.com Launches Online Store for Earth Day Network 3Health News:The death of euthanasia 2Health News:Black Women in U.S. Comfortable With Formula Feeding 2Health News:Clues to pregnancy-associated breast cancer found 2Health News:Researchers identify potential new target for treating hepatitis C 2Health News:Diabetics Face Higher Death Risk After Cancer Surgery 2Health News:Diabetics Face Higher Death Risk After Cancer Surgery 3
... scaleable device that works with ... plasma or buffy coat. The ... must be prepared independently using ... volume and concentration factor can ...
Avitene Microfibrillar Collagen (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical....
The Ultrafoam Collagen Sponge is indicated in all surgical procedures as an adjunct to hemostasis when control by ligature or conventional procedures are ineffective or impractical....
Exclusive oxidized regenerated cellulose technology. The only oxidized regenerated cellulose hemostat line, surgicel absorbable hemostat delivers a unique combination of effectiveness, absorbability,...
Medicine Products: